Sudarshan Chemical Industries Ltd
Sudarshan Chemical Industries Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #51 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Legacy Sudarshan business: Expected to return to its long-term growth rate of around 10-11% CAGR, with growth resuming from Q4 FY '26 onwards. Legacy Sudarshan business is expected to return to a long-term sustainable growth rate of around 10%-11% CAGR (Rajesh Rathi, Page 13). - The company anticipates gradual improvement in operating performance with cost optimization and working capital initiatives, resulting in building up to ~10% margin or close to EUR 90-100 million EBITDA over the next few years (Page 14). - Synergies and cost savings pipeline is strong, with a 3-4 year target to deliver EUR 90-100 million EBITDA largely through cost reduction and normalized sales (Page 9). - The impact of inventory reduction (EUR 30-40 million reduction) will positively affect cash flow and net debt but may temporarily suppress reported EBITDA by EUR 9-12 million over the next 3 quarters, normalizing thereafter (Page 6-7). - Confident of improved profitability from Q4 FY26 onwards supported by customer restocking and demand recovery (Page 14).
From Sudarshan Chemical Industries Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Legacy Sudarshan business: Expected to return to its long-term growth rate of around 10-11% CAGR, with growth resuming from Q4 FY '26 onwards.
- Acquired business (Heubach): Anticipated sales growth after inventory destocking phase; production volumes will initially lag sales, normalizing post-Q2 FY '27.
- Demand Improvement: Customers showed subdued demand in first 7-8 months but demand improved substantially after November, indicating recovery.
- New product investments in legacy business are performing well, with growing demand and potential margin improvements.
2 more points from Sudarshan Chemical Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Sudarshan Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Sudarshan Chemical Industries is focusing on cost reduction and value capture initiatives across operations, procurement, organization, IT, and fixed costs, aiming for EUR 90-100 million EBITDA in 3-4 years.
- The company has inaugurated a Global Capability Center (GCC) on February 4, 2026, aiming to ramp up operations over the next year and improve productivity and response time via digital innovation.
- There is a major initiative to harmonize multiple SAP systems into one by December 2026, enhancing efficiency by simplifying invoicing and process integration.
2 more points from Sudarshan Chemical Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sudarshan Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Management expressed confidence in demand improvement starting January and early February, indicating a positive trend in order inflow.
- Customers had promised to start buying after January, reflecting an uptick in orderbook.
- The subdued demand in prior quarters was mainly due to customer destocking rather than weak end-market orders.
- Confidence seems based on renewed customer buying behavior and market recovery.
2 more points from Sudarshan Chemical Industries Ltd's call on order book
Create a free account to keep reading this call
Sudarshan Chemical Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.8K Cr, net profit ₹82 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sudarshan Chem.'s management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Neochem Bio (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chem. (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- IVP (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sudarshan Chemical Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sudarshan Chemical Industries Ltd Q3 FY26 results?
Legacy Sudarshan business: Expected to return to its long-term growth rate of around 10-11% CAGR, with growth resuming from Q4 FY '26 onwards. Legacy Sudarshan business is expected to return to a long-term sustainable growth rate of around 10%-11% CAGR (Rajesh Rathi, Page 13). - The company anticipates gradual improvement in operating performance with cost optimization and working capital initiatives, resulting in building up to ~10% margin or close to EUR 90-100 million EBITDA over the next few years (Page 14). - Synergies and cost savings pipeline is strong, with a 3-4 year target to deliver EUR 90-100 million EBITDA largely through cost reduction and normalized sales (Page 9). - The impact of inventory reduction (EUR 30-40 million reduction) will positively affect cash flow and net debt but may temporarily suppress reported EBITDA by EUR 9-12 million over the next 3 quarters, normalizing thereafter (Page 6-7). - Confident of improved profitability from Q4 FY26 onwards supported by customer restocking and demand recovery (Page 14).
What is Sudarshan Chemical Industries Ltd share price analysis?
Sudarshan Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 465.3 with a market cap of ₹8,633 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sudarshan Chemical Industries Ltd planning capital expenditure?
Sudarshan Chemical Industries is focusing on cost reduction and value capture initiatives across operations, procurement, organization, IT, and fixed costs, aiming for EUR 90-100 million EBITDA in 3-4 years.
Keep Sudarshan Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.